Urbach–Wiethe disease
(Redirected from Lipoid proteinosis)
Urbach–Wiethe disease (also known as lipoid proteinosis) is a rare genetic disorder characterized by the deposition of a glycoprotein material in the skin, mucous membranes, and various internal organs. The disease is named after the two scientists, Erich Urbach and Camillo Wiethe, who first described it in 1929.
Clinical Features[edit | edit source]
The clinical manifestations of Urbach–Wiethe disease are diverse and can affect multiple systems in the body. Common features include:
- **Skin**: Thickening of the skin, particularly around the face and neck, leading to a waxy appearance. Verrucous lesions may also be present.
- **Mucous Membranes**: Hoarseness due to thickening of the vocal cords, which can lead to difficulty speaking.
- **Neurological**: Calcifications in the temporal lobe of the brain, particularly the amygdala, which can result in a variety of neurological symptoms, including seizures and emotional disturbances.
Pathophysiology[edit | edit source]
Urbach–Wiethe disease is caused by mutations in the ECM1 gene, which encodes the extracellular matrix protein 1. This protein is involved in the structural integrity of the skin and other tissues. Mutations in ECM1 lead to the abnormal deposition of glycoprotein material, resulting in the characteristic symptoms of the disease.
Diagnosis[edit | edit source]
Diagnosis of Urbach–Wiethe disease is typically based on clinical findings and confirmed by genetic testing. Skin biopsy may show characteristic histological features, such as the presence of periodic acid-Schiff (PAS)-positive material.
Treatment[edit | edit source]
There is currently no cure for Urbach–Wiethe disease. Treatment is symptomatic and supportive, focusing on managing individual symptoms. For example, dermatological treatments may be used for skin lesions, and speech therapy may help with vocal cord involvement.
Epidemiology[edit | edit source]
Urbach–Wiethe disease is extremely rare, with only a few hundred cases reported worldwide. It affects both males and females equally and can present at any age, although symptoms often begin in childhood.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
-
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD